AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Community Safety and Violence

Recruitingn/aAges any - anyAllNYU Langone Health
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study will describe, estimate, and explore the effectiveness of community-centered safety models (CCSMs)-including co-response, alternative response, and community violence intervention modalities-implemented across U.S. municipalities to prevent community violence among youth and young adults (YYA). Specifically, the investigators will (1) describe CCSM implementation using implementation-science methods, (2) estimate CCSMs' impacts on community-violence outcomes using quasi-experimental methods, and (3) explore operational and contextual factors associated with stronger or weaker effects.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria for Jurisdiction/Sites: 1. Intervention modality clarity: A single, identifiable CCSM-Co-Response (CRM), Alternative Response (ARM), or Community Violence Intervention (CVI)-implemented at city/county level. 2. Documented launch date \& scope: Public or official documentation specifying program start date, catchment, operating hours, staffing, eligibility, and core activities. 3. Observation window: โ‰ฅ24 months pre-implementation and โ‰ฅ12 months post-implementation of outcome data (monthly preferred; annual acceptable for fatal outcomes). 4. Outcomes coverage: Availability of primary outcomes (fatal and nonfatal violent injury) and at least one secondary justice outcome at the jurisdiction level. 5. Data quality: Stable geographic boundaries, consistent reporting practices, and no catastrophic breaks that preclude credible counterfactual fit. 6. Donor comparability: Jurisdiction characteristics and data cadence compatible with a pooled augmented synthetic control design (i.e., can be matched to a synthetic control and included in permutation tests). Exclusion Criteria: 1. Pilot-only or indeterminate programs: Short-lived pilots, ambiguous or multi-modality rollouts where treatment timing or content cannot be reliably defined. 2. Severe data discontinuity: Major boundary changes, reporting suspensions, coding overhauls, or dataset gaps that undermine time-series integrity (e.g., prolonged outages during system migration) and cannot be addressed with standard remedies. 3. Overlapping major interventions: Concurrent, poorly measured citywide initiatives (e.g., sweeping policy bundles) that coincide with the CCSM start and make identification infeasible. 4. Insufficient pre-period: \<24 months pre-implementation data for primary outcomes. 5. Incompatible cadence/aggregation: Outcomes only available at spatial or temporal units that cannot be aligned with other sites or donors.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
NYU Langone Health
New York, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy